company background image
VTI logo

Visioneering Technologies ASX:VTI Stock Report

Last Price

AU$0.14

Market Cap

AU$8.0m

7D

-15.6%

1Y

-44.9%

Updated

26 Apr, 2024

Data

Company Financials

Visioneering Technologies, Inc.

ASX:VTI Stock Report

Market Cap: AU$8.0m

VTI Stock Overview

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific.

VTI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Visioneering Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Visioneering Technologies
Historical stock prices
Current Share PriceAU$0.14
52 Week HighAU$0.42
52 Week LowAU$0.14
Beta1.65
1 Month Change-25.00%
3 Month Change-48.08%
1 Year Change-44.90%
3 Year Change-90.36%
5 Year Change-98.18%
Change since IPO-99.70%

Recent News & Updates

Recent updates

Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Sep 23
Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Shareholder Returns

VTIAU Medical EquipmentAU Market
7D-15.6%0.3%0.4%
1Y-44.9%13.9%6.0%

Return vs Industry: VTI underperformed the Australian Medical Equipment industry which returned 13.9% over the past year.

Return vs Market: VTI underperformed the Australian Market which returned 6% over the past year.

Price Volatility

Is VTI's price volatile compared to industry and market?
VTI volatility
VTI Average Weekly Movement16.0%
Medical Equipment Industry Average Movement10.2%
Market Average Movement8.9%
10% most volatile stocks in AU Market17.6%
10% least volatile stocks in AU Market3.5%

Stable Share Price: VTI's share price has been volatile over the past 3 months.

Volatility Over Time: VTI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2008n/aJuan Aragonwww.vtivision.com

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies, Inc. Fundamentals Summary

How do Visioneering Technologies's earnings and revenue compare to its market cap?
VTI fundamental statistics
Market capAU$8.00m
Earnings (TTM)-AU$5.29m
Revenue (TTM)AU$13.28m

0.6x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VTI income statement (TTM)
RevenueUS$8.67m
Cost of RevenueUS$6.09m
Gross ProfitUS$2.58m
Other ExpensesUS$6.03m
Earnings-US$3.45m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.063
Gross Margin29.71%
Net Profit Margin-39.80%
Debt/Equity Ratio0%

How did VTI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.